13-Employee SoCal Startup Bioniz Has A $400 Million Valuation Post author:Sam Post published:December 19, 2017 Post category:BioPharma Forbes recently interviewed Nazli Azimi, the CEO and co-founder of Bioniz Therapeutics. Source: BioSpace You Might Also Like Alder BioPharmaceuticals Announces Closing of $250M of 2.50% Convertible Senior Notes Due 2025 February 1, 2018 Aptinyx Bags $70M Financing to Fuel Expanding Pipeline December 17, 2017 Why This Tiny New Jersey Biotech Looks Like in 1986 June 11, 2017
Alder BioPharmaceuticals Announces Closing of $250M of 2.50% Convertible Senior Notes Due 2025 February 1, 2018
